» Articles » PMID: 32079267

Ethyl Acetate Fraction of Aqueous Extract of Lentinula Edodes Inhibits Osteoclastogenesis by Suppressing NFATc1 Expression

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2020 Feb 22
PMID 32079267
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Bone tissue is continuously remodeled by the coordinated action of osteoclasts and osteoblasts. Nuclear factor-activated T cells c1 (NFATc1) is a well-known transcription factor for osteoclastogenesis and transcriptionally activated by the c-Fos and nuclear factor-kappa B (NF-κB) signaling pathways in response to receptor activation of NF-κB ligand (RANKL). Since excessive RANKL signaling causes an increase of osteoclast formation and bone resorption, inhibition of RANKL or its signaling pathway is an attractive therapeutic approach to the treatment of pathologic bone loss. In this study, we show that an ethyl acetate fraction (LEA) from the shiitake mushroom, Lentinula edodes, inhibited RANKL-induced osteoclast differentiation by blocking the NFATc1 signaling pathway. We found that the water extract and its subsequent ethyl acetate fraction of L. edodes significantly suppressed osteoclast formation. Comparative transcriptome analysis revealed that LEA specifically downregulated a set of RANKL target genes, including Nfatc1. Next, we found that LEA suppresses Nfatc1 expression mainly through the inhibition of the transactivity of p65 and NFATc1. Moreover, treatment of LEA rescued an osteoporotic phenotype in a zebrafish model of glucocorticoid-induced osteoporosis. Collectively, our findings define an undocumented role of the shiitake mushroom extract in regulating bone development.

Citing Articles

Adaptation responses to salt stress in the gut of .

Lee H, Yeo H, Park J, Kang K, Yi S, Kim K Anim Cells Syst (Seoul). 2025; 29(1):84-99.

PMID: 39839657 PMC: 11749108. DOI: 10.1080/19768354.2025.2451413.


Denatonium inhibits RANKL-induced osteoclast differentiation and rescues the osteoporotic phenotype by blocking p65 signaling pathway.

Lee S, Lee H, Jang Y, Lee K, Kim H, Lee J Mol Med. 2024; 30(1):248.

PMID: 39701944 PMC: 11660935. DOI: 10.1186/s10020-024-01031-2.


Experimental Models in Unraveling the Biological Mechanisms of Mushroom-Derived Bioactives against Aging- and Lifestyle-Related Diseases: A Review.

Sharika R, Mongkolpobsin K, Rangsinth P, Prasanth M, Nilkhet S, Pradniwat P Nutrients. 2024; 16(16).

PMID: 39203820 PMC: 11357205. DOI: 10.3390/nu16162682.


Medicinal Mushrooms as Multicomponent Mixtures-Demonstrated with the Example of .

Lindequist U J Fungi (Basel). 2024; 10(2).

PMID: 38392825 PMC: 10890338. DOI: 10.3390/jof10020153.


TMBIM6 deficiency leads to bone loss by accelerating osteoclastogenesis.

Yi S, Jang Y, Lee S, Cho S, Kang K, Park J Redox Biol. 2023; 64:102804.

PMID: 37399733 PMC: 10336580. DOI: 10.1016/j.redox.2023.102804.


References
1.
Crockett J, Rogers M, Coxon F, Hocking L, Helfrich M . Bone remodelling at a glance. J Cell Sci. 2011; 124(Pt 7):991-8. DOI: 10.1242/jcs.063032. View

2.
Hwang Y, Jang S, Kim T, Ha H . Protects against Bone Loss in Ovariectomized Mice. Nutrients. 2019; 11(8). PMC: 6722587. DOI: 10.3390/nu11081831. View

3.
Fang N, Li Q, Yu S, Zhang J, He L, Ronis M . Inhibition of growth and induction of apoptosis in human cancer cell lines by an ethyl acetate fraction from shiitake mushrooms. J Altern Complement Med. 2006; 12(2):125-32. DOI: 10.1089/acm.2006.12.125. View

4.
Hirasawa M, Shouji N, Neta T, Fukushima K, Takada K . Three kinds of antibacterial substances from Lentinus edodes (Berk.) Sing. (Shiitake, an edible mushroom). Int J Antimicrob Agents. 1999; 11(2):151-7. DOI: 10.1016/s0924-8579(98)00084-3. View

5.
Tanaka K, Matsui Y, Ishikawa S, Kawanishi T, Harada M . Oral ingestion of Lentinula edodes mycelia extract can restore the antitumor T cell response of mice inoculated with colon-26 cells into the subserosal space of the cecum. Oncol Rep. 2011; 27(2):325-32. DOI: 10.3892/or.2011.1549. View